Skip to main content

and
  1. No Access

    Article

    Are quality-adjusted medical prices declining for chronic disease? Evidence from diabetes care in four health systems

    Improvements in medical treatment have contributed to rising health spending. Yet there is relatively little evidence on whether the spending increase is “worth it” in the sense of producing better health outc...

    Karen Eggleston, Brian K. Chen, Chih-Hung Chen in The European Journal of Health Economics (2020)

  2. No Access

    Article

    Assessing Taiwan’s pay-for-performance program for diabetes care: a cost–benefit net value approach

    Pay-for-Performance (P4P) to better manage chronic conditions has yielded mixed results. A better understanding of the cost and benefit of P4P is needed to improve program assessment. To this end, we assessed ...

    Jui-fen Rachel Lu, Ying Isabel Chen in The European Journal of Health Economics (2023)